SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000885590-18-000020
Filing Date
2018-03-27
Accepted
2018-03-26 17:45:10
Documents
5
Period of Report
2018-03-26
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K valeantlclosing8-k032620182.htm 8-K 40142
2 EXHIBIT 4.1 a90716981v2-valeantxindent.htm EX-4.1 1212913
3 EXHIBIT 99.1 a20180326-newsreleasexvale.htm EX-99.1 31851
4 valeantlogofooter2.gif GRAPHIC 8312
5 valeantlogoheader.jpg GRAPHIC 17603
  Complete submission text file 0000885590-18-000020.txt   1322147
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 18713679
SIC: 2834 Pharmaceutical Preparations